Skip to main content Back to Top


Ammonium Molybdate Injection

Products Affected - Description

    • Ammonium Molybdate injection, American Regent, 25 mcg/mL, 10 mL vial, 25 count, NDC 00517-6610-25

Reason for the Shortage

    • American Regent is not marketing ammonium molybdate injection.
    • American Regent was the sole supplier to ammonium molybdate injection.

Available Products

    • There are no presentations available.

Estimated Resupply Dates

    • American Regent is not marketing ammonium molybdate injection.

Alternative Agents & Management

    • The American Society for Parenteral and Enteral Nutrition (ASPEN) does not have recommendations for managing the ammonium molybdate shortage specifically, however, they do have detailed recommendations for managing other trace element shortages online at Key recommendations include: 1. Reserve supplies for neonatal or pediatric patients or other vulnerable groups such as patients with short bowel or malabsorption syndromes. 2. Avoid use of pediatric trace elements for adult patients. 3. Adult trace element products are not recommended for pediatric patients. 4. Consider oral or enteral multivitamin or multimineral products for supplementation if possible. 5. Avoid using trace elements additives in IV fluids. 6. Increase vigilance of signs and symptoms of trace element deficiencies. 7. Purchase only the supply needed, do not stockpile.


Updated September 26, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 21, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.



Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.